Cent Eur J Public Health 2017, 25(1):15-21

Prevalence of Diet Atherogenicity and Coexistence of Lipid Disorders and Arterial Hypertension among 50-year-old Inhabitants of Wroclaw, Poland

Bożena Regulska-Ilow1, Anna Mandecka1, Rafał Ilow2, Alicja Kowalisko3, Klaudia Konikowska1
1 Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland
2 Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland
3 Cardiology Centre "Pro Corde", Wroclaw, Poland

Objective: The incorrect composition of a diet, its atherogenicity, is conducive to the occurrence of lipid disorders, arterial hypertension (HTN), diabetes, and metabolic syndrome (MetS). The aim of the study was to evaluate the prevalence of incorrect anthropometric and biochemical parameters as well as diet atherogenicity.

Methods: The study group included 1,520 adults (880 women, 640 men). The nutritional status evaluation was based on respondents' BMI and waist circumference. The diet atherogenicity was estimated using Keys Index (KI) and P/S ratio. Total cholesterol (TCh), LDL cholesterol as well as triglycerides (TG) concentration in blood serum were also evaluated.

Results: In 56.8% of women and 60.8% of men waist circumference exceeded referential values. The diets of 71.4% of women and 87.3% of men were atherogenic. HTN was observed in 64.1% of the study population. Hypercholesterolaemia was found in approximately 72% of the respondents. The increased LDL cholesterol concentration were found in 57.5% of women and 64.5% of men. Abnormal concentration of HDL cholesterol occurred among approximately 20% of respondents. Hypertriglyceridaemia was recognised in 26% of women and 44% of men. In the group of women and men with HTN, mean values, i.e. BMI, waist circumference and TG (with TCh concentration additionally noted in men) were found as significant. Normal lipid profile and arterial pressure values were observed in 6.6% of the population.

Conclusions: In the diets of men with HTN were observed higher values of KI compared to group without HTN. No significant differences were found in the frequency of occurrence of the analysed parameters either among the group of women with HTN or without it. In the group of men with HTN, the abnormal BMI, waist circumference and TG occurred more frequently.

Klíčová slova: diet atherogenicity, hypertension, obesity, lipid profile

Vloženo: 30. březen 2015; Revidováno: 24. listopad 2016; Přijato: 24. listopad 2016; Zveřejněno: 1. březen 2017  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Regulska-Ilow B, Mandecka A, Ilow R, Kowalisko A, Konikowska K. Prevalence of Diet Atherogenicity and Coexistence of Lipid Disorders and Arterial Hypertension among 50-year-old Inhabitants of Wroclaw, Poland. Cent Eur J Public Health. 2017;25(1):15-21. PubMed PMID: 28399350.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011 May 5;9:48. doi: 10.1186/1741-7015-9-48. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Mendizábal Y, Llorens S, Nava E. Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens. 2013;2013:230868. doi: 10.1155/2013/230868. Přejít k původnímu zdroji... Přejít na PubMed...
    3. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism. 2006 Jul;55(7):928-34. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Dharwadkar SM, Agate AA, Singh RB. Study of relationship between serum atherogenic lipid parameters, oxidative stress biomarkers and antioxidant vitamins in hypertension. Int J Biotechnol Biosci. 2012;2(3):190
    5. Tykarski A, Podolec P, Kopeć G, Pająk A, Kawecka-Jaszcz K, Zdrojewski T, et al. Consensus of the Editorial Board of the Polish Forum of Prevention of the Cardiovascular Diseases regarding hypertension. Forum Profilaktyki. 2006;(4):1. (In Polish.)
    6. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Oct;253:281-344. Přejít k původnímu zdroji...
    7. Wożakowska-Kapłoń B, Salwa P, Siebert J. New European guidelines for the management of arterial hypertension- do they really influence clinical practice? Folia Cardiol. 2014;9(1):33-53. (In Polish.)
    8. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al.; EuropeanAssociation for Cardiovascular Prevention & Rehabilitation (EACPR).; ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012 Jul;33(13):1635-701. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas I, Stefanadis C; ATTICA Study. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study. Vasc Med. 2008;13(2):113-21. Přejít k původnímu zdroji... Přejít na PubMed...
    10. Simonds SE, Cowley MA. Hypertension in obesity: is leptin the culprit? Trends Neurosci. 2013 Feb;36(2):121-32. Přejít k původnímu zdroji... Přejít na PubMed...
    11. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: WHO; 2000.
    12. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. Metabolism. 1965 Jul;14(7):776-87. Přejít k původnímu zdroji...
    13. Mamcarz A, Podolec P, Kopeć G, Czarnecka D, RynkiewiczA, Stańczyk J, et al. Consensus of the PFP Working Group concerning the metabolic syndrome. Forum Profilaktyki. 2009;(2):1. (In Polish.)
    14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. Přejít k původnímu zdroji...
    15. Panagiotakos DB, Pitsavos C, Lentzas Y, Chrysohoou C, Stefanadis C. Five-year incidence of hypertension and its determinants: the ATTICA study. J Hum Hypertens. 2007 Aug;21(8):686-8. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Khaw KT, Wareham N, Bingham S, WelchA, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPICNorfolk prospective population study. PLoS Med. 2008 Jan 8;5(1):e12. doi: 10.1371/journal.pmed.0050012. Přejít k původnímu zdroji... Přejít na PubMed...
    17. Zatońska K, Campos H, Ilow R, Janik-Koncewicz K, Różańska D, Regulska-Ilow B, et al. Dietary intake and adipose tissue level of specific fatty acids in a selected group from the Lower Silesia population. Ann Agric Environ Med. 2012;19(3):389-94.
    18. Rywik SL, Davis CE, Pajak A, Broda G, Folsom AR, Kawalec E, et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICAProject and the U.S.Atherosclerosis Risk in Communities Study.Ann Epidemiol. 1998 Jan;8(1):3-13. Přejít k původnímu zdroji...
    19. Rywik S, Piotrowski W, Pająk A, Broda G, Rywik T. Relationship between metabolic disturbances and overweight or obesity in a random sample of Polish population aged 20-74 years - the Pol-MONICABis Project. Med Metabol. 2003;7(2):16-24. (In Polish.)
    20. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003 Nov;42(5):878-84. Přejít k původnímu zdroji... Přejít na PubMed...
    21. Beasley J, Viswanathan S, Wylie-Rosett J. Associations between change in DASH diet scores and CVD risk factors in the PREMIER Trial. FASEB J. 2014;28(Suppl. 369.1). Přejít k původnímu zdroji...
    22. Hoffmann K, Bryl W, Strażyńska A, Miczke A, Cymerys M, Kramer L, et al. The assessment of adiponectin and insulin concentrations selected metabolic parameters, family history and anthropometric factors in young population with primary arterial hypertension. Nadciśnienie Tętnicze. 2008;12(5):359-66. (In Polish.)
    23. Strażyńska A, Bryl W, Hoffmann K, Miczke A, Cymerys M, Rzesoś A, et al. Leptin and insulin concentrations, lipid profile and anthropometric parameters in young adults with primary arterial hypertension. Nadciśnienie Tętnicze. 2008;12(6):424-31. (In Polish.)
    24. Wolańska D, Kłosiewicz-Latoszek L. Fatty acids intake and serum lipids profile in overweighted and obese adults. Rocz Panstw Zakl Hig. 2012;63(2):155-62. (In Polish.) Přejít na PubMed...
    25. Carlsson CM, Nondahl DM, Klein BE, McBride PE, Sager MA, Schubert CR, et al. Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis. Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):11-7. Přejít k původnímu zdroji...
    26. Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb. 2009 Jun;16(3):145-54. Přejít k původnímu zdroji...
    27. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707-14. Přejít k původnímu zdroji... Přejít na PubMed...
    28. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al.; Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteinsA-I and B, and HDLdensity subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001 Sep 4;104(10):1108-13. Přejít k původnímu zdroji...
    29. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dazu VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90(4):1248-53. Přejít k původnímu zdroji... Přejít na PubMed...
    30. Dash SC, Mishra J, Patro S, Mishra S, Dash DD. Prevalence of diabetes, hypertension, renal dysfunction and hyperlipidemia among doctors of a Medical College in Odisha. Int J Physiol. 2013;1(2):130-4. Přejít k původnímu zdroji...

    Zpět na obsah